Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Ciprandi

Showing results (1-10 of 545) with videos related to

Pageof 55
Sort By:
Allergo Journal International|January 18, 2021
Tablet allergen immunotherapy (TAIT) requires tight managementGiorgio Ciprandi
Patient Preference and Adherence|January 6, 2011
Clinical utility and patient adherence with ebastine for allergic rhinitisGiorgio Ciprandi
Iranian Journal of Allergy, Asthma, and Immunology|April 19, 2017
Symptom Severity and Allergen-specific IgE in Allergic RhinitisGiorgio Ciprandi
Minerva Pediatrics|February 26, 2024
The updated role of budesonide in managing children and adolescents with allergic rhinitisGiorgio Ciprandi
Children (Basel, Switzerland)|April 23, 2022
Pediatric Asthma: A Daily ChallengeGiorgio Ciprandi
Panminerva Medica|July 17, 2024
Budesonide aqueous nasal spray: an updated review in managing chronic rhinosinusitis with nasal polypsGiorgio Ciprandi
Minerva Medica|February 28, 2024
Budenoside aqueous nasal spray: an updated reappraisal in rhinitis managementGiorgio Ciprandi
Minerva Pediatrics|June 13, 2025
Natural antitussive products for children and adolescents: darkness and shadowGiorgio Ciprandi,
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 4, 2017
Fractional exhaled nitric oxide, methacholine, or forced expiratory flow between 25% and 75%: What's better in the daily clinical practice?Giorgio Ciprandi
Clinical Laboratory|February 7, 2017
Allergen Extract or Molecule: That is the QuestionGiorgio Ciprandi
Pageof 55

Showing results (1-10 of 545) with videos related to

Sort By:
Pageof 55
Allergo Journal International|January 18, 2021
Tablet allergen immunotherapy (TAIT) requires tight managementGiorgio Ciprandi
Patient Preference and Adherence|January 6, 2011
Clinical utility and patient adherence with ebastine for allergic rhinitisGiorgio Ciprandi
Iranian Journal of Allergy, Asthma, and Immunology|April 19, 2017
Symptom Severity and Allergen-specific IgE in Allergic RhinitisGiorgio Ciprandi
Minerva Pediatrics|February 26, 2024
The updated role of budesonide in managing children and adolescents with allergic rhinitisGiorgio Ciprandi
Children (Basel, Switzerland)|April 23, 2022
Pediatric Asthma: A Daily ChallengeGiorgio Ciprandi
Panminerva Medica|July 17, 2024
Budesonide aqueous nasal spray: an updated review in managing chronic rhinosinusitis with nasal polypsGiorgio Ciprandi
Minerva Medica|February 28, 2024
Budenoside aqueous nasal spray: an updated reappraisal in rhinitis managementGiorgio Ciprandi
Minerva Pediatrics|June 13, 2025
Natural antitussive products for children and adolescents: darkness and shadowGiorgio Ciprandi,
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 4, 2017
Fractional exhaled nitric oxide, methacholine, or forced expiratory flow between 25% and 75%: What's better in the daily clinical practice?Giorgio Ciprandi
Clinical Laboratory|February 7, 2017
Allergen Extract or Molecule: That is the QuestionGiorgio Ciprandi
Pageof 55